OLIGONUCLÉOTIDES À IMMUNOSUPPRESSION INVERSÉE INHIBANT L'EXPRESSION DE LA TDO

• 收藏
• 分享

专利权人:

Secarna Pharmaceuticals GmbH & Co. KG

发明人:

申请号：

EP17150683.5

公开号：

EP3346007A1

申请日:

2017.01.09

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

The present invention refers to an immunosuppression-reverting oligonucleotide hybridizing with a nucleic acid sequence of tryptophan-2,3-dioxygenase (TDO) and a pharmaceutical composition comprising such immunosuppression-reverting oligonucleotide and a pharmaceutically acceptable carrier, excipient and/or diluent. The oligonucleotide and the pharmaceutical composition, respectively, is used in a method for preventing and/or treating an autoimmune disorder, an immune disorder, a psychiatric disorder and/or cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/